Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
4.040
-0.240 (-5.61%)
Oct 23, 2026, 1:05 PM EDT - Market open
Adicet Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -98.97 | -116.8 | -117.12 | -142.66 | -69.79 | -62 |
Depreciation & Amortization | 5.59 | 6.38 | 6.47 | 6.1 | 2.58 | 1.54 |
Other Amortization | 0.03 | 0.04 | 0.04 | 0.03 | 0.09 | 0.18 |
Loss (Gain) From Sale of Assets | - | 0.1 | - | -0 | 0.05 | 0.03 |
Asset Writedown & Restructuring Costs | - | - | - | 19.46 | - | 1.19 |
Loss (Gain) From Sale of Investments | -3.34 | -4.09 | -1.67 | - | - | 0.01 |
Stock-Based Compensation | 10.92 | 14.27 | 22.23 | 20.26 | 17.13 | 12.51 |
Other Operating Activities | 3.21 | 3.38 | 3.2 | 2.84 | 2.43 | 1.55 |
Change in Accounts Receivable | - | - | - | - | - | -0.03 |
Change in Accounts Payable | 0.38 | 1.03 | 1.11 | -1.68 | 1.71 | 1.14 |
Change in Unearned Revenue | - | - | - | - | -4.81 | -9.18 |
Change in Other Net Operating Assets | -2.35 | 0.44 | -6.63 | 1.94 | 5.84 | 2.01 |
Operating Cash Flow | -84.53 | -95.25 | -92.38 | -93.72 | -44.77 | -51.05 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.44 | -1.74 | -1.12 | -4.46 | -16.78 | -13.05 |
Investment in Securities | 8.27 | 4.13 | -118.12 | - | - | 10.25 |
Investing Cash Flow | 7.83 | 2.39 | -119.24 | -4.46 | -16.78 | -2.8 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.15 | - | - | - | - |
Net Debt Issued (Repaid) | -0.15 | -0.15 | - | - | - | - |
Issuance of Common Stock | 75.32 | 75.5 | 111.45 | 0.39 | 45.11 | 242.95 |
Repurchase of Common Stock | -0.07 | -0.1 | -0.14 | -0.15 | -3.23 | - |
Other Financing Activities | -0.02 | - | - | - | -0.36 | -0.26 |
Financing Cash Flow | 75.08 | 75.25 | 111.31 | 0.24 | 41.51 | 242.69 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -1.62 | -17.61 | -100.31 | -97.95 | -20.04 | 188.84 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -84.97 | -96.98 | -93.5 | -98.18 | -61.55 | -64.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -246.29% | -658.77% |
Free Cash Flow Per Share | -9.03 | -14.07 | -17.02 | -36.50 | -23.97 | -33.13 |
Levered Free Cash Flow | -47.52 | -53.87 | -53.22 | -61.28 | -38.41 | -42.27 |
Unlevered Free Cash Flow | -47.49 | -53.89 | -53.25 | -61.3 | -38.45 | -42.33 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | - | - | - | - | - | -2.72 |
Change in Working Capital | -1.96 | 1.47 | -5.53 | 0.25 | 2.74 | -6.06 |